Cronos Group

Canopy signs cannabis seed deal with Spanish pharma company

Canopy Growth will supply medical marijuana seeds to the Spanish pharmaceutical company Alcaliber, becoming the latest licensed Canadian producer to expand its footprint in Europe. Alcaliber will use the seeds to grow and export medical cannabis from its facilities in Spain. The seeds will be provided through a supply deal involving Smiths Falls, Ontario-based Canopy and […]

Read More

Manitoba First Nation takes stake in medical cannabis company

A Manitoba First Nation is making a major investment in a Canadian company that operates medical cannabis clinics, adding itself to a growing list of indigenous communities getting involved in the MMJ sector. The Opaskwayak Cree Nation, located 530 kilometers (329 miles) northwest of Winnipeg, Manitoba, has purchased 3 million Canadian dollars ($2.5 million) worth […]

Read More

Canada’s Cronos dips toes in Caribbean medical cannabis market

Cronos Group is exporting medical marijuana oil to the Cayman Islands, making it the second Canadian MMJ producer to ship the product to the Caribbean island. CEO Mike Gorenstein described the sale – the company’s first to the Caribbean – as a “trial run” before larger shipments are sent. “We absolutely expect this to be a […]

Read More

Canada’s Cronos secures $32M for big indoor marijuana facility

Cronos Group secured 40 million Canadian dollars ($32 million) for the continued construction of its 315,000-square-foot new Peace facility in Stayner, Ontario, which it says is the largest purpose-built indoor cannabis production facility in the world. Cronos, based in Toronto and traded on the TSX Venture Exchange, entered into a commitment letter for CA$40 million […]

Read More

Medical marijuana companies in Canada capitalizing on ‘insane’ growth abroad

By Matt Lamers

Canadian medical marijuana companies are primed to tap what one industry executive calls “insane” growth overseas.

Flush with capital and largely free from American competition, Canadian licensed producers are spreading their wings to gain a first-mover advantage in new markets as more countries legalize marijuana for medical use.

Read More